GemVax revealed Tuesday that its peptide drug candidate GV1001 missed the mark in a phase 2a study in progressive supranuclear ... GV1001 0.56 mg or GV1001 1.12 mg, the company said.
The study met its primary and secondary endpoints ... Dementia Rating Scale Sum of Boxes (CDR-SOB) on Day 148 was 1.401 in the LD IL-2 q4wks group, 1.976 in the LD IL-2 q2wks group, and 1.893 ...
Retired Gen. Mark A. Welsh III stepped into the presidency at Texas A&M University at a critical time. Many faculty felt burned by the past president’s decision-making process, and state lawmakers had ...